Authors:
ELIAS D
DEALBUQUERQUE AC
EGGENSPIELER P
PLAUD B
DUCREUX M
SPIELMANN M
THEODORE C
BONVALOT S
LASSER P
Citation: D. Elias et al., RESECTION OF LIVER METASTASES FROM A NONCOLORECTAL PRIMARY - INDICATIONS AND RESULTS BASED ON 147 MONOCENTRIC PATIENTS, Journal of the American College of Surgeons, 187(5), 1998, pp. 487-493
Authors:
KEPKA L
DELASSENCE A
RIBRAG V
GACHOT B
BLOT F
THEODORE C
BONNAY M
KORENBAUM C
NITENBERG G
Citation: L. Kepka et al., SUCCESSFUL RESCUE IN A PATIENT WITH HIGH-DOSE METHOTREXATE-INDUCED NEPHROTOXICITY AND ACUTE-RENAL-FAILURE, Leukemia & lymphoma, 29(1-2), 1998, pp. 205-209
Authors:
FIZAZI K
CULINE S
DROZ JP
TERRIERLACOMBE MJ
THEODORE C
WIBAULT P
RIXE O
RUFFIE P
LECHEVALIER T
Citation: K. Fizazi et al., INITIAL MANAGEMENT OF PRIMARY MEDIASTINAL SEMINOMA - RADIOTHERAPY OR CISPLATIN-BASED CHEMOTHERAPY, European journal of cancer, 34(3), 1998, pp. 347-352
Authors:
CULINE S
ABS L
TERRIERLACOMBE MJ
THEODORE C
WIBAULT P
DROZ JP
Citation: S. Culine et al., CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED SEMINOMA - THE INSTITUT-GUSTAVE-ROUSSY EXPERIENCE, European journal of cancer, 34(3), 1998, pp. 353-358
Authors:
REBISCHUNG C
FIZAZI K
DABAN A
TERRIERLACOMBE MJ
DROZ JP
CULINE S
THEODORE C
Citation: C. Rebischung et al., GERM-CELL TUMORS CONTAINING NON GERM-CELL NEOPLASMS - THE SO-CALLED TERATOMA WITH MALIGNANT TRANSFORMATION (TMT), Annals of oncology, 9, 1998, pp. 281-281
Authors:
FIZAZI K
CULINE S
DROZ JP
KRAMAR A
THEODORE C
RUFFIE P
LECHEVALIER T
Citation: K. Fizazi et al., PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMORS - RESULTS OF MODERN THERAPY INCLUDING CISPLATIN-BASED CHEMOTHERAPY, Journal of clinical oncology, 16(2), 1998, pp. 725-732
Authors:
CULINE S
KATTAN J
ZANETTA S
THEODORE C
FIZAZI K
DROZ JP
Citation: S. Culine et al., EVALUATION OF ESTRAMUSTINE PHOSPHATE COMBINED WITH WEEKLY DOXORUBICININ PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, American journal of clinical oncology, 21(5), 1998, pp. 470-474
Authors:
PETRUCKEVITCH A
DELAMO J
PHILLIPS AN
JOHNSON AM
STEPHENSON J
DESMOND N
HANSCHEID T
LOW N
NEWELL A
OBASI A
PAINE K
PYM A
THEODORE C
DECOCK KM
Citation: A. Petruckevitch et al., DISEASE PROGRESSION AND SURVIVAL FOLLOWING SPECIFIC AIDS-DEFINING CONDITIONS - A RETROSPECTIVE COHORT STUDY OF 2048 HIV-INFECTED PERSONS INLONDON, AIDS, 12(9), 1998, pp. 1007-1013
Authors:
CULINE S
THEODORE C
BEKRADDA M
FARHAT F
TERRIERLACOMBE MJ
DROZ JP
Citation: S. Culine et al., EXPERIENCE WITH BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) AND ALTERNATINGCISPLATIN, CYCLOPHOSPHAMIDE, DOXORUBICIN (CISCA(II)) VINBLASTINE, BLEOMYCIN (VBIV) REGIMENS OF CHEMOTHERAPY IN POOR-RISK NONSEMINOMATOUS GERM-CELL TUMORS, American journal of clinical oncology, 20(2), 1997, pp. 184-188
Citation: G. Crowe et al., ACCEPTABILITY AND COMPLIANCE WITH DAILY INJECTIONS OF PROCAINE PENICILLIN IN THE OUTPATIENT TREATMENT OF SYPHILIS-TREPONEMAL INFECTION, Sexually transmitted diseases, 24(3), 1997, pp. 127-130
Authors:
CULINE S
THEODORE C
TERRIERLACOMBE MJ
DROZ JP
Citation: S. Culine et al., ARE 3 CYCLES OF BLEOMYCIN, ETOPOSIDE AND CISPLATIN OR 4 CYCLES OF ETOPOSIDE AND CISPLATIN EQUIVALENT OPTIMAL REGIMENS FOR PATIENTS WITH GOOD RISK METASTATIC GERM-CELL TUMORS OF THE TESTIS - THE NEED FOR A RANDOMIZED TRIAL, The Journal of urology, 157(3), 1997, pp. 855-858
Authors:
CULINE S
PHILIPPOT I
FARHAT F
THEODORE C
TERRIERLACOMBE MJ
DROZ JP
Citation: S. Culine et al., EVALUATION OF LONG-TERM RESULTS OF A MODIFIED VAB-6 CHEMOTHERAPY REGIMEN IN A COHORT OF GOOD-RISK METASTATIC NON SEMINOMATOUS GERM-CELL TUMORS, Bulletin du cancer, 84(4), 1997, pp. 368-372
Authors:
FIZAZI K
CULINE S
DROZ JP
LECHEVALIER T
RUFFIE P
THEODORE C
Citation: K. Fizazi et al., PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM- CELL TUMORS - FROM CLINICS TO BIOLOGY, Bulletin du cancer, 84(3), 1997, pp. 313-327
Authors:
CULINE S
THEODORE C
COURT BH
PERRIN JL
DROZ JP
Citation: S. Culine et al., EVALUATION OF PRIMARY STANDARD CISPLATIN-BASED CHEMOTHERAPY FOR CLINICAL STAGE-II NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS, British Journal of Urology, 79(2), 1997, pp. 258-262
Authors:
FIZAZI K
FARHAT F
THEODORE C
RIXE O
LECESNE A
COMOY E
LECHEVALIER T
Citation: K. Fizazi et al., CA125 AND NEURON-SPECIFIC ENOLASE (NSE) AS TUMOR-MARKERS FOR INTRAABDOMINAL DESMOPLASTIC SMALL ROUND-CELL TUMORS, British Journal of Cancer, 75(1), 1997, pp. 76-78
Authors:
CORTI C
THEODORE C
BAYLE C
ROUGIER P
NASR F
COSSET JM
GIRINSKY T
HAYAT M
RIBRAG V
Citation: C. Corti et al., HIGH-INCIDENCE OF SECONDARY MYELODYSPLASTIC SYNDROMES FOLLOWING PROMACE-MOPP AND INVOLVED FIELD RADIOTHERAPY FOR LOCALIZED GASTRIC NON-HODGKINS-LYMPHOMAS, Hematological oncology, 14(4), 1996, pp. 159-163
Authors:
CULINE S
THEODORE C
TERRIERLACOMBE MJ
DROZ JP
Citation: S. Culine et al., PRIMARY CHEMOTHERAPY IN PATIENTS WITH NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS AND BIOLOGICAL DISEASE ONLY AFTER ORCHIECTOMY, The Journal of urology, 155(4), 1996, pp. 1296-1298
Authors:
CULINE S
THEODORE C
FARHAT F
BEKRADDA M
TERRIERLACOMBE MJ
DROZ JP
Citation: S. Culine et al., CISPLATIN-BASED CHEMOTHERAPY AFTER RETROPERITONEAL LYMPH-NODE DISSECTION IN PATIENTS WITH PATHOLOGICAL STAGE-II NONSEMINOMATOUS GERM-CELL TUMORS, Journal of surgical oncology, 61(3), 1996, pp. 195-198
Authors:
FARHAT F
CULINE S
LHOMME C
DUVILLARD P
SOULIE P
MICHEL G
TERRIERLACOMBE MJ
THEODORE C
SCHREINEROVA M
DROZ JP
Citation: F. Farhat et al., DESMOPLASTIC SMALL ROUND-CELL TUMORS - RESULTS OF A 4-DRUG CHEMOTHERAPY REGIMEN IN 5 ADULT PATIENTS, Cancer, 77(7), 1996, pp. 1363-1366
Authors:
FARHAT F
CULINE S
THEODORE C
BEKRADDA M
TERRIERLACOMBE MJ
DROZ JP
Citation: F. Farhat et al., CISPLATIN AND IFOSFAMIDE WITH EITHER VINBLASTINE OR ETOPOSIDE AS SALVAGE THERAPY FOR REFRACTORY OR RELAPSING GERM-CELL TUMOR PATIENTS - THEINSTITUT-GUSTAVE-ROUSSY EXPERIENCE, Cancer, 77(6), 1996, pp. 1193-1197
Citation: J. Kattan et al., PHASE-II TRIAL OF IFOSFAMIDE, FLUOROURACIL, AND FOLINIC ACID (FIFO REGIMEN) IN RELAPSED AND REFRACTORY UROTHELIAL CANCER, Cancer investigation, 13(3), 1995, pp. 276-279
Authors:
ESCUDIER B
FARACE F
THEODORE C
ANGEVIN E
COURT B
COUANET D
DIETRICH PY
CULINE S
PALLARDY M
HERCEND T
DROZ JP
Citation: B. Escudier et al., A NEW SCHEDULE OF INTERLEUKIN-2 FOR METASTATIC RENAL-CELL CARCINOMA -THE INSTITUT GUSTAVE-ROUSSY STUDY, Bulletin du cancer, 82(4), 1995, pp. 296-302